NCT00158678View on ClinicalTrials.gov

IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC

PHASE3CompletedINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

September 27, 2005

Primary Completion Date

March 22, 2020

Study Completion Date

March 22, 2020

Conditions
Oral CancerOropharynx CancerHypopharynx Cancer
Interventions
PROCEDURE

IMRT 75 Gy

50 Gy in PTV1 and 25 Gy in 10 fractions in PTV2

PROCEDURE

Conventional radiotherapy 70 Gy

50 Gy in PTV1 and 20 Gy in PTV2

DRUG

concomitant cisplatin

100 mg/m2 D1, D22, D43

Trial Locations (2)

54511

Centre Alexis Vautrin, Vandœuvre-lès-Nancy

94800

Institut Gustave Roussy, Villejuif

All Listed Sponsors
lead

Groupe Oncologie Radiotherapie Tete et Cou

OTHER

NCT00158678 - IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC | Biotech Hunter | Biotech Hunter